# BAXFENDY
> **NDA219878** · New Drug Application · Sponsor: ASTRAZENECA AB · Approved 2026-05-15
## Drug
- **FDA Application Number:** NDA219878
- **Application type:** New Drug Application
- **Brand name:** BAXFENDY
- **Generic name:** Baxdrostat
- **Active ingredients:** BAXDROSTAT
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** ASTRAZENECA AB
- **First approval:** 2026-05-15
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219878)
---
*MORVS · CC0 1.0*